# Ajanta Pharma Ltd. – FDA Inspection, Feb 7, 2017

Source: https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/69d66c75-a99f-42cb-bbb1-29c81e157e1a
Source feed: FDA_Inspections

> FDA inspection 1009806 of Ajanta Pharma Ltd., February 07, 2017. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009806
- Company Name: Ajanta Pharma Ltd.
- Inspection Date: 2017-02-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1313426 - 2026-04-21](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/6118c3f9-60aa-44a4-ae82-113ff53e50a0)
- FDA Inspection 1235564 - 2024-03-05
- [FDA Inspection 1097061 - 2019-06-28](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/dcc8e789-9501-4bd0-9137-a7594d3fd15c)
- FDA Inspection 917795 - 2015-03-20
- FDA Inspection 801522 - 2012-09-06

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)

Company: https://www.keypedia.com/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c